Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AspECT: Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
NCT00357682Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Mar 2005
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of esomeprazole, aspirin in esophageal cancer, Barrett's esophagus, sponsored by University of Oxford. Started Mar 2005; status: completed.
02
Drugs
esomeprazoleaspirin
03
Conditions
esophageal cancerBarrett's esophagus
Beyond the preview
Go deeper on NCT00357682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00357682.